CVTX's Ranexa appears to have 2 serious side effects, prolongation of QT interval and testicular toxicity. I cant imagine any doctor would use it to control angina only to have the patient die from atrial fibrillation. There are plenty good medications in existence to battle angina. I would say the chance of Ranexa getting approved is only 50%
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.